Related Experiment Video
Updated: Jul 15, 2026

Sequential In vivo Imaging of Osteogenic Stem/Progenitor Cells During Fracture Repair
Published on: May 23, 2014
Isovitexin can Alleviate Fracture-Related Infection, Promote Osteogenesis, and Inhibit Activation of the NF-κB
1Disinfection Supply Center, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, Suzhou, Jiangsu 215101, China.
Isovitexin, a natural flavonoid, effectively combats fracture-related infections by reducing inflammation and promoting bone healing. It inhibits the NF-κB pathway, offering a potential new therapeutic option for orthopedic infections.
Area of Science:
- Orthopedics
- Pharmacology
- Immunology
Background:
- Fracture-related infections impede bone healing and cause prolonged inflammation.
- The therapeutic potential of isovitexin, a natural flavonoid, in fracture infection remains unexplored.
- Current treatments face challenges in managing infection and promoting bone regeneration.
Purpose of the Study:
- To investigate the efficacy of isovitexin in a rat model of fracture-related infection.
- To evaluate isovitexin's effects on bone healing, inflammation, and related molecular pathways.
- To determine if isovitexin can serve as a viable therapeutic agent for fracture infections.
Main Methods:
- Established a rat fracture infection model, divided into control, model, Vancomycin, and isovitexin groups.
- Assessed bone healing via tissue staining and measured inflammatory factors and bone metabolism using ELISA and biochemical kits.
- Examined osteogenesis and NF-κB pathway protein expression via Western blot.
Main Results:
- Isovitexin significantly reduced inflammatory cell infiltration and enhanced callus formation compared to Vancomycin.
- Isovitexin treatment improved bone metabolism, upregulated osteogenic proteins (BMP2, OPN, RUNX2), and modulated inflammatory cytokines (decreased TNF-α, IL-6; increased IL-10).
- Isovitexin markedly inhibited the activation of the Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathway.
Conclusions:
- Isovitexin demonstrates potent anti-inflammatory and bone-healing properties in fracture-related infections.
- Isovitexin promotes osteogenesis and suppresses the NF-κB signaling pathway, mitigating infection-induced inflammation.
- Isovitexin presents a promising therapeutic candidate for managing fracture-related infections and enhancing bone repair.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Inhibitors of Viral Protein Synthesis
TGF - β Signaling Pathway
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Bone Remodeling and Repair
